Medical Condition News

RSS

Extended-release ketamine tablets offer new hope for treatment-resistant depression

The BEDROC trial found that extended-release ketamine tablets (R-107) significantly improve depressive symptoms in treatment-resistant depression patients, with the 180 mg dose showing the most efficacy. The treatment was well-tolerated with minimal side effects.

26 Jun 2024

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

The FLOW trial demonstrated that semaglutide significantly improves kidney and cardiovascular outcomes in people with chronic kidney disease and type 2 diabetes, irrespective of SGLT2 inhibitor use.

25 Jun 2024

Innovative insulin algorithm enhances glucose control for hospitalized patients

Hospitalized patients with complex dietary restrictions often develop hyperglycemia, or high blood sugar.

25 Jun 2024

Breakthrough biomarker predicts recurrence risk in clear cell renal cancer

Researchers from the University of Michigan Health Rogel Cancer Center have discovered a biomarker that could help identify which renal cancer patients have a higher risk of recurrence.

25 Jun 2024

New curative treatment for sickle cell disease shows promising results in international trial

Vanderbilt University Medical Center (VUMC) researchers are touting data from a multicenter, international phase 2 clinical trial showing a new, curative treatment for sickle cell disease (SCD).

25 Jun 2024

New report highlights the urgent need for gender-specific cardiovascular research and care

Cardiovascular disease is the leading cause of death for women, and gaps in care and access persist between women and men.

25 Jun 2024

Pentraxin 3 as a predictor of advanced fibrosis and carotid intima-media thickness in MAFLD patients

Metabolic-associated fatty liver disease (MAFLD) may increase the risk of cardiovascular events. In this study, we assessed the predictive value of pentraxin 3 (PTX3) for severe fibrosis and carotid intima-media thickness (CIMT) in patients with MAFLD.

25 Jun 2024

Combining CYFRA 21-1 with CXCR1 and cxcr2 levels for predicting recurrence in stage III squamous cell lung carcinoma

Despite efforts, tumor recurrence is diagnosed in 35–40% of patients with stage III squamous cell lung carcinoma (SCLC) during the first year after treatment.

25 Jun 2024

Senecavirus A could be a promising new therapeutic approach for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a highly aggressive tumor with limited treatment options and high mortality.

25 Jun 2024

Using real-world data to assess medication-related liver toxicity

The current method for assessing medication-related liver injury is not providing an accurate picture of some medications' toxicity-;or lack thereof-;to the liver, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania.

25 Jun 2024

MRI connectome predicts gray matter atrophy progression in early Parkinson's disease

The structural and functional organization of the brain as shown on MRI can predict the progression of brain atrophy in patients with early-stage, mild Parkinson's disease, according to a study published today in Radiology, a journal of the Radiological Society of North America (RSNA).

25 Jun 2024

Single-image 3D modeling of the colon can enable rapid disease diagnosis

Using just a single image taken by a capsule endoscopy camera, scientists have succeeded in creating a three-dimensional model of the colon. This new method provides much better images and can help specialists detect disease more rapidly.

25 Jun 2024

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

The use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as "ecstasy", to support psychotherapy for mental illnesses such as post-traumatic stress disorder is being discussed worldwide.

25 Jun 2024

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park Comprehensive Cancer Center.

25 Jun 2024

Automated prediction of Alzheimer's disease progression using speech and machine learning

Trying to figure out whether someone has Alzheimer's disease usually involves a battery of assessments-;interviews, brain imaging, blood and cerebrospinal fluid tests.

25 Jun 2024

Genetic variation in people of African ancestry linked to increased risk of diabetes complications

A genetic variation common in people of African ancestry is associated with an increased risk of complications from diabetes, including diabetic retinopathy, according to a report published June 25 in the journal Nature Medicine.

25 Jun 2024

Nitrate from plant sources linked to lower risk of mortality

New research from Edith Cowan University (ECU) has found that nitrate from plant sources is associated with a lower risk of mortality while nitrate from other sources such as animal-based foods, processed meat and tap water, is linked to a higher risk of mortality.

25 Jun 2024

Wearable devices show how sleep patterns change with health conditions

Examine changes in the sleep phenotype of an individual over time and to determine if these changes in sleep patterns or phenotypes are informative about periods of acute illness.

25 Jun 2024

Research shows gut bacteria's role in mental resilience and reduced anxiety

Researchers characterized brain-gut microbiome (BGM) patterns related to stress resilience.

25 Jun 2024

Open-source platform enables high-definition spatial transcriptomics

An open-source platform developed by researchers in Nikolaus Rajewsky's lab at the Max Delbrück Center creates molecular maps from patient tissue samples with subcellular precision, enabling detailed study and potentially enhancing routine clinical pathology. The study was published in "Cell."

25 Jun 2024

Medical Condition News

Extended-release ketamine tablets offer new hope for treatment-resistant depression

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

Innovative insulin algorithm enhances glucose control for hospitalized patients

Breakthrough biomarker predicts recurrence risk in clear cell renal cancer

New curative treatment for sickle cell disease shows promising results in international trial

New report highlights the urgent need for gender-specific cardiovascular research and care

Pentraxin 3 as a predictor of advanced fibrosis and carotid intima-media thickness in MAFLD patients

Combining CYFRA 21-1 with CXCR1 and cxcr2 levels for predicting recurrence in stage III squamous cell lung carcinoma

Senecavirus A could be a promising new therapeutic approach for hepatocellular carcinoma

Using real-world data to assess medication-related liver toxicity

MRI connectome predicts gray matter atrophy progression in early Parkinson's disease

Single-image 3D modeling of the colon can enable rapid disease diagnosis

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

Automated prediction of Alzheimer's disease progression using speech and machine learning

Genetic variation in people of African ancestry linked to increased risk of diabetes complications

Nitrate from plant sources linked to lower risk of mortality

Wearable devices show how sleep patterns change with health conditions

Research shows gut bacteria's role in mental resilience and reduced anxiety

Open-source platform enables high-definition spatial transcriptomics

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News